Investigation of suitable administration-time of GLP-1 receptor agonist on glycemic control in patients with type 2 diabetes: multicenter-randomized non-blind study - Study of suitable administration-time of liraglutide (morning vs. evening): Time study

Dokkyo Medical University Koshigaya Hospital Internal Medicine0 个研究点目标入组 300 人开始时间: 2010年12月25日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Patients with hypersensitivity for liraglutide 2)Patients who developed diabetic ketoacidosis, diabetic coma 3)Patients with type 1 diabetes 4)Patients with severe infection, liver dysfunction[AST>=80IU/L, ALT>=80IU/L], and renal dysfunction [serum creatinine>=1.7mg/mL] 5)Patients under artificial dialysis 6)Patients with severe heart disease (NYHA3-4) 7)Patients with oral anti-diabetic drugs except for SUs, or insulin at initiation of liraglutide therapy 8)Patients with past history of pancreatitis 9)Patients with diabetic gastroparesis or gastrointestinal disease such as inflammatory bowel disease 10)Patients in pregnancy, during lactation, or having possibility of pregnancy 11)Patients with pasthistory of medullary thyroid cancer,Patients with family history of medullary thyroid cancer,and multiple endocrine neoplasia type 2 12)Patients who was comsident to be inadequate for enrollment in this study by doctors

发起方

Dokkyo Medical University Koshigaya Hospital Internal Medicine